These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20923687)

  • 1. Invariant natural killer T (iNKT) cell deficiency in chronic mucocutaneous candidiasis--a consequence or a cause?
    Ng WF; Tudhope SJ; von Delwig A; Lilic D
    Immunol Lett; 2011 Mar; 135(1-2):180-3. PubMed ID: 20923687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIRE deficiency leads to impaired iNKT cell development.
    Lindh E; Rosmaraki E; Berg L; Brauner H; Karlsson MC; Peltonen L; Höglund P; Winqvist O
    J Autoimmun; 2010 Feb; 34(1):66-72. PubMed ID: 19651488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.
    Eyerich K; Rombold S; Foerster S; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
    Arch Dermatol Res; 2007 Dec; 299(10):475-81. PubMed ID: 17960405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
    Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
    J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis.
    van der Graaf CA; Netea MG; Drenth IP; te Morsche RH; van der Meer JW; Kullberg BJ
    Neth J Med; 2003 Nov; 61(11):365-9. PubMed ID: 14768719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.
    van de Veerdonk FL; Plantinga TS; Hoischen A; Smeekens SP; Joosten LA; Gilissen C; Arts P; Rosentul DC; Carmichael AJ; Smits-van der Graaf CA; Kullberg BJ; van der Meer JW; Lilic D; Veltman JA; Netea MG
    N Engl J Med; 2011 Jul; 365(1):54-61. PubMed ID: 21714643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency.
    Kalfa VC; Roberts RL; Stiehm ER
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):259-64. PubMed ID: 12602677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound invariant natural killer T-cell deficiency in inflammatory arthritis.
    Tudhope SJ; von Delwig A; Falconer J; Pratt A; Woolridge T; Wilson G; Isaacs JD; Ng WF
    Ann Rheum Dis; 2010 Oct; 69(10):1873-9. PubMed ID: 20444757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
    Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
    Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.
    Hong M; Ryan KR; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning DW; McConnell V; Cant AJ; Abinun M; Spickett GP; Swan DC; Gillespie CS; Young DA; Lilic D
    Clin Exp Immunol; 2009 Apr; 156(1):40-51. PubMed ID: 19196253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
    Hanna S; Etzioni A
    J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic mucocutaneous candidiasis, from bench to bedside.
    Eyerich K; Eyerich S; Hiller J; Behrendt H; Traidl-Hoffmann C
    Eur J Dermatol; 2010; 20(3):260-5. PubMed ID: 20133219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
    Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
    Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.
    Cervato S; Mariniello B; Lazzarotto F; Morlin L; Zanchetta R; Radetti G; De Luca F; Valenzise M; Giordano R; Rizzo D; Giordano C; Betterle C
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):421-8. PubMed ID: 18616706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mixed lymphocyte reaction in man. XI. Deficiency of autologous mixed lymphocyte reaction and abnormalities of monoclonal antibody-defined T-cell subsets in chronic mucocutaneous candidiasis.
    Gupta S
    Scand J Immunol; 1985 Jun; 21(6):525-30. PubMed ID: 2992070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis.
    Barnaba V; Zaccari C; Levrero M; Balsano F
    Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients.
    Faiyaz-Ul-Haque M; Bin-Abbas B; Al-Abdullatif A; Abdullah Abalkhail H; Toulimat M; Al-Gazlan S; Almutawa AM; Al-Sagheir A; Peltekova I; Al-Dayel F; Zaidi SH
    Clin Genet; 2009 Nov; 76(5):431-40. PubMed ID: 19758376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens.
    Brännström J; Hässler S; Peltonen L; Herrmann B; Winqvist O
    Clin Immunol; 2006 Dec; 121(3):265-73. PubMed ID: 16982213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis.
    Parietti V; Chifflot H; Sibilia J; Muller S; Monneaux F
    Clin Immunol; 2010 Mar; 134(3):331-9. PubMed ID: 20022305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
    Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
    J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.